≡

Multiplex Assay Kit for Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay)

GROg; SCYB3; GRO3; GRO-G; MIP2-B; MIP2b; CINC2b; CINC2b; Growth Regulated Oncogene Gamma; Macrophage inflammatory protein 2-beta

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-90 85
EDTA plasma(n=5) 98-105 102
heparin plasma(n=5) 83-97 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-99% 91-101% 91-105% 81-91%
EDTA plasma(n=5) 86-95% 80-97% 88-102% 80-103%
heparin plasma(n=5) 84-93% 88-97% 82-95% 90-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CXCL3) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS One. Inconformity of CXCL3 Plasma Level and Placenta Expression in Preeclampsia and Its Effect on Trophoblast Viability and Invasion Pubmed:25485631
Scientific Reports Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis. pubmed:28272440
Medicine (Baltimore) Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity Pubmed:29953010
Anticancer Research The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer Pubmed: 31810929
SCIENCE OF THE TOTAL ENVIRONMENT Assessment of acute toxicological effects of molybdenum (IV) disulfide nano-and microparticles after single intratracheal administration in rats Pubmed: 32629262
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB604Hu01 Active Chemokine (C-X-C Motif) Ligand 3 (CXCL3) Cell culture; Activity Assays.
RPB604Hu01 Recombinant Chemokine (C-X-C Motif) Ligand 3 (CXCL3) Positive Control; Immunogen; SDS-PAGE; WB.
RPB604Hu02 Recombinant Chemokine (C-X-C Motif) Ligand 3 (CXCL3) Positive Control; Immunogen; SDS-PAGE; WB.
PAB604Hu01 Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 3 (CXCL3) WB; IHC; ICC; IP.
PAB604Hu02 Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 3 (CXCL3) WB; IHC; ICC; IP.
LAB604Hu71 Biotin-Linked Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 3 (CXCL3) WB; IHC; ICC.
LAB604Hu81 FITC-Linked Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 3 (CXCL3) WB; IHC; ICC; IF.
MAB604Hu22 Monoclonal Antibody to Chemokine (C-X-C Motif) Ligand 3 (CXCL3) WB; IHC; ICC; IP.
SEB604Hu ELISA Kit for Chemokine (C-X-C Motif) Ligand 3 (CXCL3) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB604Hu Multiplex Assay Kit for Chemokine (C-X-C Motif) Ligand 3 (CXCL3) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB604Hu01 ELISA Kit DIY Materials for Chemokine (C-X-C Motif) Ligand 3 (CXCL3) Main materials for "Do It (ELISA Kit) Yourself".